- Home
- UPLD vs ABVC Comparison
UPLD vs ABVC Comparison
Compare UPLD & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPLD | ABVC |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 58.6M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | UPLD | ABVC |
|---|---|---|
| Price | $1.42 | $2.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 208.6K | 84.1K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $235,591,000.00 | $797,916.00 |
| Revenue This Year | N/A | $735.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 56.52 |
| 52 Week Low | $1.39 | $0.40 |
| 52 Week High | $4.98 | $5.48 |
Technical Indicators
Market Signals| Indicator | UPLD | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 29.43 | 38.75 |
| Support Level | $1.40 | $2.25 |
| Resistance Level | $1.53 | $2.53 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 9.37 | 20.35 |
Price Performance
Historical ComparisonAbout UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.